gamma-aminobutyric acid has been researched along with Esophageal Diseases in 2 studies
gamma-Aminobutyric Acid: The most common inhibitory neurotransmitter in the central nervous system.
gamma-aminobutyric acid : A gamma-amino acid that is butanoic acid with the amino substituent located at C-4.
Esophageal Diseases: Pathological processes in the ESOPHAGUS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To study the effects of pregabalin on development of secondary oesophageal hypersensitivity in healthy humans." | 9.16 | Randomised clinical trial: pregabalin attenuates the development of acid-induced oesophageal hypersensitivity in healthy volunteers - a placebo-controlled study. ( Aziz, Q; Chua, YC; Jafari, J; Knowles, CH; Ng, KS; Sharma, A; Surguy, S; Yazaki, E, 2012) |
| "Pregabalin attenuates development of secondary hypersensitivity in the proximal oesophagus after distal oesophageal acidification; it may thus have a role in treatment of patients with proven oesophageal pain hypersensitivity." | 9.16 | Randomised clinical trial: pregabalin attenuates the development of acid-induced oesophageal hypersensitivity in healthy volunteers - a placebo-controlled study. ( Aziz, Q; Chua, YC; Jafari, J; Knowles, CH; Ng, KS; Sharma, A; Surguy, S; Yazaki, E, 2012) |
| "To study the effects of pregabalin on development of secondary oesophageal hypersensitivity in healthy humans." | 5.16 | Randomised clinical trial: pregabalin attenuates the development of acid-induced oesophageal hypersensitivity in healthy volunteers - a placebo-controlled study. ( Aziz, Q; Chua, YC; Jafari, J; Knowles, CH; Ng, KS; Sharma, A; Surguy, S; Yazaki, E, 2012) |
| "Pregabalin attenuates development of secondary hypersensitivity in the proximal oesophagus after distal oesophageal acidification; it may thus have a role in treatment of patients with proven oesophageal pain hypersensitivity." | 5.16 | Randomised clinical trial: pregabalin attenuates the development of acid-induced oesophageal hypersensitivity in healthy volunteers - a placebo-controlled study. ( Aziz, Q; Chua, YC; Jafari, J; Knowles, CH; Ng, KS; Sharma, A; Surguy, S; Yazaki, E, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chua, YC | 1 |
| Ng, KS | 1 |
| Sharma, A | 1 |
| Jafari, J | 1 |
| Surguy, S | 1 |
| Yazaki, E | 1 |
| Knowles, CH | 1 |
| Aziz, Q | 1 |
| Oh, TH | 1 |
| Fass, R | 1 |
1 trial available for gamma-aminobutyric acid and Esophageal Diseases
| Article | Year |
|---|---|
Randomised clinical trial: pregabalin attenuates the development of acid-induced oesophageal hypersensitivity in healthy volunteers - a placebo-controlled study.
Topics: Adult; Analgesics; Cross-Over Studies; Double-Blind Method; Esophageal Diseases; Female; gamma-Amino | 2012 |
1 other study available for gamma-aminobutyric acid and Esophageal Diseases
| Article | Year |
|---|---|
Commentary: effect of pregabalin on acid-induced oesophageal hypersensitivity.
Topics: Analgesics; Esophageal Diseases; Female; gamma-Aminobutyric Acid; Humans; Male; Pain | 2012 |